| Mrs Renee Linda Barta, OTR | |
|
515 22nd Ave, Monroe, WI 53566-1569 | |
| (608) 324-2000 | |
| Not Available |
| Full Name | Mrs Renee Linda Barta |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 515 22nd Ave, Monroe, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568511608 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2734-026 (Wisconsin) | Primary |
| 225X00000X | Occupational Therapist | (Illinois) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Renee Linda Barta, OTR N2252 Asmus Rd, Monroe, WI 53566-8932 Ph: () - | Mrs Renee Linda Barta, OTR 515 22nd Ave, Monroe, WI 53566-1569 Ph: (608) 324-2000 |
News Archive
Imagine a classroom of normal healthy teenage girls. As many as half of them may grow up and develop anxiety and depression. But which ones will they be?
NextGen Group plc is pleased to announce that its US-subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched its first cerebrospinal fluid (CSF) multiple protein assay, csfdiscovery43, for central nervous system (CNS) biomarker discovery and qualification.
Researchers at Cincinnati Children's Hospital Medical Center have developed a tool to rapidly assess the risk of aggressive and violent behavior by children and adolescents hospitalized on psychiatric units. Ultimately, they hope to use the questionnaire to improve treatment and prevention of aggressive behavior in schools and in the community.
A research team from the School of Life Sciences at The Chinese University of Hong Kong has recently discovered that SOX9 protein is an essential regulatory factor of choroid plexus function that ensures the correct composition of cerebrospinal fluid (CSF).
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Bayer Schering Pharma AG, Germany. The milestone was triggered by Bayer's submission of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for MN-IC, an ADC for solid tumors.
› Verified 4 days ago
Alexa Beyer, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 516 26th Ave, Monroe, WI 53566 Phone: 608-325-9141 | |
Mrs. Jaclyn M Foltz, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1178 | |
Morgan Lynn Kamholz, MS, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1178 | |
Mrs. Catherine Agnes Darga, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 516 26th Ave, Monroe, WI 53566 Phone: 608-325-9141 Fax: 608-329-6594 | |
Mrs. Kendra Shelton, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1175 | |
Mrs. Hayley L Jordan, OTRL, CLT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-2770 Fax: 608-324-2469 | |
Jessica Ryan Dahms, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1178 |